ORENCIA

E.R. Squibb & Sons, L.L.C.🇺🇸 United States

FDA Page

Effective Date: Oct 30, 2023
Approval ID: 0836c6ac-ee37-5640-2fed-a3185a0b16eb
Products: 4 registered
Version: 32

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use ORENCIA safely and effectively. See full prescribing information for ORENCIA. ORENCIA (abatacept) for injection, for intravenous useORENCIA (abatacept) injection, for subcutaneous useInitial U.S. Approval: 2005

Quick Stats

Total Products4

Labelers2

Label Sections44

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.